367
Views
0
CrossRef citations to date
0
Altmetric
Reports

Probiotics in the Arabian Gulf Region

Article: 1842 | Received 15 Jun 2008, Published online: 04 Mar 2009

References

  • FAO/WHO. Report of a joint FAO/WHO expert consultation on guidelines for the evaluation of probiotics in food. LondonOntario, Canada: World Health Organization and Food Agriculture Organization of the United Nations.2002.
  • Senok AC, Ismaeel AY, Botta GA. Probiotics: facts and myths. Clin Microbiol Infect. 2005; 11: 958–66.
  • Stanton C, Gardiner G, Meehan H, Collins K, Fitzgerald G, Lynch PB, et al.. Market potential for probiotics. Am J Clin Nutr. 2001; 73: 476–484S.
  • Brink M, Senekal M, Dicks LM. Market and product assessment of probiotic/prebiotic-containing functional foods and supplements manufactured in South Africa. S Afr Med J. 2005; 95: 114–9.
  • Coeuret V, Gueguen M, Vernoux JP. Numbers and strains of lactobacilli in some probiotic products. Int J Food Microbiol. 2004; 97: 147–56.
  • Drisko J, Bischoff B, Giles C, Adelson M, Rao RV, McCallum R. Evaluation of five probiotic products for label claims by DNA extraction and polymerase chain reaction analysis. Dig Dis Sci. 2005; 50: 1113–7.
  • Huys G, Vancanneyt M, D'Haene K, Vankerckhoven V, Goossens H, Swings J. Accuracy of species identity of commercial bacterial cultures intended for probiotic or nutritional use. Res Microbiol. 2006; 157: 803–10.
  • Saldanha LG. US Food and Drug Administration regulations governing label claims for food products, including probiotics. Clin Infect Dis. 2008; 46: S119–21.
  • Theunissen J, Britz TJ, Torriani S, Witthuhn RC. Identification of probiotic microorganisms in South African products using PCR-based DGGE analysis. Int J Food Microbiol. 2005; 98: 11–21.
  • Weese JS. Microbiologic evaluation of commercial probiotics. J Am Vet Med Assoc. 2002; 220: 794–7.
  • Hamilton-Miller JM, Shah S, Winkler JT. Public health issues arising from microbiological and labelling quality of foods and supplements containing probiotic microorganisms. Public Health Nutr. 1999; 2: 223–9.
  • Perea Velez M, Hermans K, Verhoeven TL, Lebeer SE, Vanderleyden J, De Keersmaecker SC. Identification and characterization of starter lactic acid bacteria and probiotics from Columbian dairy products. J Appl Microbiol. 2007; 103: 666–74.
  • Amagase H. Current marketplace for probiotics: a Japanese perspective. Clin Infect Dis. 2008; 46: S73–5.
  • Reid G, Anukam K, Koyama T. Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend?. Can J Gastroenterol. 2008; 22: 169–75.
  • FAO/WHO. Report of a Joint FAO/WHO Expert Consultation on evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. LondonOntario, Canada: World Health Organization and Food Agriculture Organization of the United Nations.2001.
  • Holzapfel WH, Haberer P, Geisen R, Bjorkroth J, Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr. 2001; 73: 365–373S.
  • Pestka JJ, Ha CL, Warner RW, Lee JH, Ustunol Z. Effects of ingestion of yogurts containing Bifidobacterium and Lactobacillus acidophilus on spleen and Peyer's patch lymphocyte populations in the mouse. J Food Prot. 2001; 64: 392–5.
  • Tejada-Simon MV, Lee JH, Ustunol Z, Pestka JJ. Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice. J Dairy Sci. 1999; 82: 649–60.
  • de Vrese M, Stegelmann A, Richter B, Fenselau S, Laue C, Schrezenmeir J. Probiotics – compensation for lactase insufficiency. Am J Clin Nutr. 2001; 73: 421–29S.
  • Eaton TJ, Gasson MJ. Molecular screening of Enterococcus virulence determinants and potential for genetic exchange between food and medical isolates. Appl Environ Microbiol. 2001; 67: 1628–35.
  • Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr. 2001; 73: 465S–70S.
  • Ibnou-Zekri N, Blum S, Schiffrin EJ, von der WT. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immunol. 2003; 71: 428–36.
  • Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev. 2003; 16: 658–72.
  • Selmer-Olsen E, Sorhaug T, Birkeland SE, Pehrson R. Survival of Lactobacillus helveticus entrapped in Ca-alginate in relation to water content, storage and rehydration. J Ind Microbiol Biotechnol. 1999; 23: 79–85.
  • Yamada K, Sato-Mito N, Nagata J, Umegaki K. Health claim evidence requirements in Japan. J Nutr. 2008; 138: 1192S–8S.
  • Asp NG, Bryngelsson S. Health claims in Europe: new legislation and PASSCLAIM for substantiation. J Nutr. 2008; 138: 1210S–5S.
  • Hasler CM. Health claims in the United States: an aid to the public or a source of confusion. J Nutr. 2008; 138: 12165–205.
  • Heimbach JT. Health-benefit claims for probiotic products. Clin Infect Dis. 2008; 46: S122–24.
  • Sullivan A, Barkholt L, Nord CE. Lactobacillus acidophilus, Bifidobacterim lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteriodes fragilis in the intestine. J Antimicrob Chemother. 2003; 52: 308–11.